Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.
Quick Stats
Feb 02, 202656.3
AI Score
HOLD0.77
Volume Ratio
Feb 26, 2026
Next Earnings
14
+ve Days (30d)
14
-ve Days (30d)
ACRS Stock Summary
Last updated Feb 02, 2026
ACRS is currently trading at $3.605, positioned above its 200-day moving average of $2.06, indicating a long-term uptrend. The stock has a 52-week range of $1.05 to $4.89.
Technical Analysis: The 50-day moving average stands at $3.1, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 55.114, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.224, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ACRS at 56.3/100 with a HOLD recommendation.
ACRS (Aclaris Therapeutics, Inc.) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 55.114 |
| CMF (20) | 0.224 |
| ROC (10) | 37.595 |
| ADX (14) | 31.091 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.216 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -55.748 |
| MFI (14) | 85.915 |
ACRS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ACRS Price vs Max Options Open Interest
ACRS Max Change In Options Open Interest
ACRS Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACRS Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACRS Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACRS Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Aclaris Therapeutics, Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.
ACRS Moving Averages Analysis
Aclaris Therapeutics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 02, 2026
Aclaris Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
ACRS (Aclaris Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 3.97 |
| 20 | 3.32 |
| 30 | 3.21 |
| 50 | 3.1 |
| 100 | 2.6 |
| 200 | 2.06 |
ACRS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 380.3 million |
| Earnings/Share ($) | -1.62 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.4967 |
| EPS Estimate Next Year ($) | -0.55 |
| WallStreet Target Price ($) | 8 |
| Most Recent Quarter |